期刊文献+

细胞衰老与抗衰老药物senolytics的研究进展 被引量:1

Current Advances in Cellular Senescence and Senolytics
原文传递
导出
摘要 细胞衰老是一种稳定的增殖抑制并伴有衰老相关的分泌表型(SASP)。其发生主要是由于细胞在复制过程中端粒酶的消耗以及外界衰老相关刺激如癌基因激活、活性氧积聚、DNA损伤等。短期内衰老细胞的产生有助于机体胚胎发育、损伤修复和肿瘤抑制等;而机体内长期积聚衰老的细胞会导致肿瘤的发生、机体老化和老化相关的疾病。近年来研究发现,特异性清除体内衰老细胞有助于延缓机体老化、重塑身体机能等;这再次将衰老相关的研究推向了一个新的高度。该文将从细胞衰老的主要特征、生理学功能、发生机制及抗衰老药物senolytics的发展等方面进行讨论,并结合相关研究的最新进展,为衰老及相关疾病的防治提供理论依据。 Cellular senescence is mainly described as a stable cell cycle arrest and SASP (senescence-associated secretory phenotype).Theoretically,senescence is mainly induced by diverse stimuli including telomere shortening,oncogene activation,oxidative stress and DNA damage.It has been demonstrated that time dependent short-term induction of cellular senescence plays beneficial roles in terms of embryonic development,wound healing and tumor suppression;whereas long-term accumulation of senescent cells in tissues is harmful and may contribute to cancer progression,aging or age-associated disorders.Recent studies have demonstrated that selectively killing senescent cells can extend healthy lifespan and restore physical function,which bring the senescence field to an even higher interesting grade than ever before.Here,the review will discuss the characters,functions and mechanisms of cellular senescence,together with the development of senolytics,thus aiming to provide theoretical targets for aging and age-related diseases.
作者 马兴杰 欧金磊 王垚 MA Xingjie;OU Jinlei;WANG Yao(Department of Intensive Care,the Affiliated Hospital of Yangzhou University,Yangzhou 225000,China;Department of Nephrology,the Affiliated Hospital of Yangzhou University,Yangzhou 225000,China)
出处 《中国细胞生物学学报》 CAS CSCD 2020年第10期1901-1908,共8页 Chinese Journal of Cell Biology
基金 扬州大学附属医院高层次人才科研启动金(批准号:2019MXJ)资助的课题。
关键词 细胞衰老 P16 P53 senolytics cellular senescence p16 p53 senolytics
  • 相关文献

参考文献4

二级参考文献117

  • 1Andrea Morgner,Stephan Miehlke,Manfred Stolte,Andreas Neubauer,Birgit Alpen,Christian Thiede,Hermann Klann,Franz-Xaver Hierlmeier,Christian Ell,Gerhard Ehninger,Ekkehard Bayerdorffer.Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pyloriassociated gastric low-grade marginal zone B-cell lymphoma of MALT type[J].World Journal of Gastroenterology,2001,7(2):248-253. 被引量:28
  • 2Tyler ZARUBIN.Activation and signaling of the p38 MAP kinase pathway[J].Cell Research,2005,15(1):11-18. 被引量:153
  • 3Vogel stein B, Lane D and Levine AJ. Surfing the p53 network. Nature 2000,408: 307-310.
  • 4Feng Z and Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Bioi 2010, 20: 427-434.
  • 5Vousden KH and Prives C. Blinded by the light: the growing complexity ofp53. Cell 2009, 137: 413-431.
  • 6Hollstein M, Sidransky D, Vogelstein B and Harris Cc. p53 mutations in human cancers. Science 1991,253: 49-53.
  • 7Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P and Harris CC. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Pub12004, 157: 247-270.
  • 8Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A and Zehbe 1. The role of TP53 in Cervical carcinogenesis. Hum Mutat 2003, 21: 307-312.
  • 9Scheffner M, Wemess BA, Huibregtse JM, Levine AJ and Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation ofp53. Cell 1990, 63: 1129-1136.
  • 10Wade M, Li YC and Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 2013, 13: 83-96.

共引文献54

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部